3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
16
Gastrointestinal
8
Genitourinary
6
Myeloid
4
Lymphoid
4
CNS
4
Gynecologic
3
Dermatologic
2
Thoracic
1
Other solid neoplasm
1
Breast
1
Conditions
Lung Neoplasms
84
Carcinoma, Non-Small-Cell Lung
61
Melanoma
13
Neoplasm Metastasis
12
Small Cell Lung Carcinoma
11
Breast Neoplasms
10
Colorectal Neoplasms
9
Carcinoma, Renal Cell
8
Ovarian Neoplasms
7
Carcinoma, Hepatocellular
7
Prostatic Neoplasms
6
Pancreatic Neoplasms
6
Brain Neoplasms
5
Adenocarcinoma of Lung
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma, Kaposi
4
Meningeal Carcinomatosis
4
Esophageal Neoplasms
4
Carcinoma, Transitional Cell
4
Triple Negative Breast Neoplasms
3
HIV Infections
3
Endometrial Neoplasms
3
Uveal Melanoma
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Rectal Neoplasms
2
Multiple Myeloma
2
Fallopian Tube Neoplasms
2
Interventions
pembrolizumab
11
Cyclophosphamide
8
Gemcitabine
7
Cisplatin
7
tislelizumab
5
Docetaxel
5
Nivolumab
4
Injections
4
spartalizumab
3
regorafenib
3
Trastuzumab
3
Oncolytic Virotherapy
3
Irinotecan
3
Filgrastim
3
Drug Therapy
3
Doxorubicin
3
Carboplatin
3
Bortezomib
3
tazemetostat
2
pazopanib
2
liposomal doxorubicin
2
ganitumab
2
conatumumab
2
belinostat
2
Temozolomide
2
Taxes
2
Tamoxifen
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Specimen Handling
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled